Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Expert Panel on Detection, EvaluationTreatment of High Blood Cholesterol in Adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluationtreatment of high blood cholesterol in adults (Adult Treatment Panel III).
Jama, 285 (2001), pp. 2486-2496
[2.]
Y. Cui, R.S. Blumenthal, J.A. Flaws, M.K. Whiteman, P. Laugenberg, P.S. Bachcrick, et al.
Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
Arch Intern Med, 161 (2001), pp. 1413-1419
[3.]
W. Lu, H.E. Resnik, K.L. Jones, A.K. Jain, D.C. Robbins, B.V. Howard.
Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes. The Strong Heart Study.
Diabetes Care, 26 (2003), pp. 16-23
[4.]
G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, E. Steiner.
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
Lancet, 358 (2001), pp. 2026-2033
[5.]
A.M. Gotto Jr., E. Whitney, E.A. Stein, D.R. Shapiro, M. Charfield, S. Weiss, et al.
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/ Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex- CAPS.
Circulation, 101 (2000), pp. 477-484
[6.]
S. Miremadi, A. Sniderman, J. Frohlich.
Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders?.
Clin Chem, 48 (2002), pp. 484-488
[7.]
A.M. Wägner, J.L. Sánchez-Quesada, A. Pérez, M. Rigla, F. Blanco-Vaca, J. Ordóñez-Llanos.
Inaccuracy of calculated LDL cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decision.
Clin Chem, 46 (2000), pp. 1830-1832
[8.]
A.M. Wägner, A. Pérez, F. Calvo, R. Bonet, A. Castellví, J. Ordóñez.
Apolipoprotein B identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
Diabetes Care, 22 (1999), pp. 812-817
[9.]
A. Sniderman, B. Lamarche, J. Tilley, D. Secombe, J. Frohlich.
Hypertriglyceridemic hyperapoB in type 2 diabetes.
Diabetes Care, 25 (2002), pp. 579-582
[10.]
G. Leroux, I. Lemieux, B. Lamarche, B. Cantin, G.R. Dagenais, P.J. Lupieu, et al.
Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.
Metabolism, 49 (2000), pp. 53-61
Copyright © 2004. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.